Acute Flaccid Myelitis: A Clinical Review

Olwen C Murphy1, Carlos A Pardo1

  • 1Johns Hopkins Myelitis and Myelopathy Center, Division of Neuroimmunology and Neurological Infections, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Seminars in Neurology
|March 7, 2020
PubMed

Insights

Acute flaccid myelitis (AFM) is a rare, polio-like illness causing sudden weakness in children. Enterovirus D68 is a suspected cause, presenting diagnostic challenges for physicians.

Area of Science:

  • Neurology
  • Pediatrics
  • Infectious Diseases

Background:

  • Acute flaccid myelitis (AFM) is an emerging neurological disorder affecting children.
  • Characterized by acute flaccid paralysis and spinal cord gray matter abnormalities.
  • Presents with polio-like symptoms, including limb weakness and potential respiratory compromise.

Purpose of the Study:

  • To review the epidemiology, clinical features, and diagnosis of AFM.
  • To discuss potential etiological factors, particularly viral links.
  • To provide insights into differential diagnosis, treatment, and outcomes.

Main Methods:

  • Review of epidemiological data and clinical case characteristics.
  • Analysis of proposed viral associations, including enterovirus D68.
  • Comparison with other causes of acute flaccid paralysis.

Main Results:

  • AFM exhibits seasonal peaks in the US, occurring biennially since 2012.
  • Nonpolio enteroviruses, especially enterovirus D68, are strongly associated.
  • Differentiating AFM from conditions like Guillain-Barre syndrome is challenging.

Conclusions:

  • AFM is a rare but significant condition requiring prompt recognition.
  • Understanding its viral etiology is crucial for diagnosis and management.
  • Further research is needed to elucidate AFM's pathogenesis and improve patient outcomes.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
193
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.0K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.1K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K